Hemophilia of Georgia will host the 25th Annual Hit ’Em for Hemophilia Golf Tournament on October 30, 2007 at Château Élan Winery and Resort in Braselton, Georgia. More than 400 corporate executives, local and sports celebrities, and invited guests are expected to participate in the tournament which also features an awards banquet, live auction, and raffle.

One of the premier charity golfing events in the Southeast, the tournament supports critical research directed toward finding a cure for hemophilia, a hereditary blood clotting disorder that requires very expensive, life-long medical treatment. Trish Dominic, Hemophilia of Georgia CEO, notes, “We’re grateful for our corporate sponsors, volunteers, and celebrity guests who have helped us to raise millions of dollars for research over the past 24 years. While there have been extraordinary advances in care and treatment in recent years, there is still no cure.”

Key corporate sponsors of the 25th Annual Hit ’Em for Hemophilia Golf Tournament include ADC Telecommunications, AT & T Mobility, LLC, Baxter Healthcare, Grifols USA, Wyeth Pharmaceuticals, and Zeliff Wallace Jackson Investment Council, Inc. Corporate sponsorship packages are still available for companies of all sizes. Contact Vic McCarty, Director of Development, (770) 518-8272 or vamccarty@hog.org for information on sponsorship and volunteer opportunities.

About Hemophilia of Georgia

Hemophilia of Georgia is a nonprofit organization dedicated to providing services and support for Georgians who have hemophilia, von Willebrand Disease, and other inherited bleeding disorders. The only agency of its kind in the state, Hemophilia of Georgia works to enhance clients’ care and quality of life while actively pursuing a cure through research funding. HoG’s nonprofit pharmacy provides convenient home delivery of clotting factor and other medications at competitive prices. The agency’s mission states that Hemophilia of Georgia exists so that people in Georgia affected by bleeding disorders live as normally and productively as possible. Additional information is available online at www.hog.org.

About Hemophilia

Hemophilia is a hereditary genetic disorder in which a person’s blood is not able to clot normally. In normal blood, proteins called clotting factors work together to form a clot whenever bleeding occurs. The person with hemophilia lacks or doesn’t have enough of a certain clotting factor so the blood can’t make a clot. Hemophilia is a very rare disorder, affecting about 17,000 people in the United States. People with hemophilia stop bleeding by taking an injection of the clotting factor that is missing from their blood. However, the clotting factor used to treat hemophilia is very expensive. Some patients reach their lifetime insurance maximum at very young ages.